National Science Foundation awarded rapid response grants to support coronavirus (COVID-19) research
On Apr. 21, 2020, the National Science Foundation (NSF) issued a letter to researchers inviting proposals for rapid…
On Apr. 21, 2020, the National Science Foundation (NSF) issued a letter to researchers inviting proposals for rapid…
On Apr. 21, 2020, Vaxart announced it had obtained positive pre-clinical results for its COVID-19 vaccine candidates, with…
On Apr. 21, 2020, aTyr Pharma announced the FDA has accepted its Investigational New Drug application to evaluate…
On Apr. 21, 2020, OpGen announced the start of an investigator initiated collaboration with Karolinska Institutet, Sweden, to…
On Apr. 21, 2020, LabCorpᆴ announced it has received an Emergency Use Authorization (EUA) from the FDA. The…
On Apr. 20, 2020, Alexion announced plans to initiate a global Phase 3 study to investigate ULTOMIRISᆴ (ravulizumab-cwvz)…
On Apr. 20, 2020, Innovation Pharma reported that based on molecular screening of 11,552 compounds comprising already FDA-approved…
On Apr. 20, 2020, VGX signed as the first occupant of Conroeメs Deison Technology Park and will move…
On Apr. 20, 2020, Atossa Therapeutics announced that it had applied to the FDA for approval to commence…
On Apr. 17, 2020, the NIH and the Foundation for the NIH are bringing together more than a…
On Apr. 16, 2020, Royal Philips and UK HealthCare, the clinical enterprise of the University of Kentucky, announced…
On Apr. 16, 2020, Scripps Research announced that researchers at Calibr, Scripp’s drug development division, had established an…
On Apr. 16, 2020, CHF Solutions announced increased utilization of its Aquadex therapy in patients affected by COVID-19….
On Apr. 16, 2020, Soligenix announced it has executed an agreement for the exclusive worldwide license of CoVaccine…
On Apr. 16, 2020, Atossa Therapeutics announced a new drug development program called COVID-19 HOPE. The program used…
On Apr. 15, 2020, the U.S. Food and Drug Administration (FDA) authorized the production and use of a…
On Apr. 15, 2020, the FDA announced it granted Emergency Use Authorization to Ortho Clinical Diagnosticsメ total antibody…
On Apr. 15, 2020, Vanda Pharma and Northwell Health’s research arm, The Feinstein Institutes for Medical Research, announced…
On Apr. 15, 2020, Chembio Diagnostics announced receipt of FDA Emergency Use Authorization (EUA) for its DPP COVID-19…
On Apr. 15, 2020, Abbott announced the launch of its third COVID-19 test, a lab-based serology blood test…
On Apr. 15, 2020, HALIX announced it had joined a consortium of partners under the guidance of the…
On Apr. 15, 2020, Getinge announced support of the Ventilator Manufacturers Group to form Ventilator Training Alliance (VTA)…
On Apr. 15, 2020, N95 respirators can be decontaminated effectively and maintain functional integrity for up to three…
On Apr. 15, 2020, Queensland University of Technology (QUT) reported it had developed and tested a highly breathable…
On Apr. 14, 2020, Royal Philips announced that it planed to double the production of its hospital ventilators…
On Apr. 14, 2020, AstraZeneca initiated a randomised, global clinical trial to assess the potential of Calquence (acalabrutinib)…
On Apr. 14, 2020, Royal Philips updated its plans to double the production of its hospital ventilators by…
On Apr. 14, 2020, Sinovac Biotech announced that the Company had obtained approval to conduct a human clinical…
On Apr. 14, 2020, Philips announced that it had joined forces with manufacturing partners Flex and Jabil to…
On Apr. 14, 2020, Philips announced its initiative to quickly scale production of its new Philips Respironics E30…